Log in to save to my catalogue

Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development

Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7355792

Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development

About this item

Full title

Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development

Publisher

Basel: MDPI AG

Journal title

Journal of clinical medicine, 2020-06, Vol.9 (6), p.2004

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Antisense oligonucleotides (ASOs) bind sequence specifically to the target RNA and modulate protein expression through several different mechanisms. The ASO field is an emerging area of drug development that targets the disease source at the RNA level and offers a promising alternative to therapies targeting downstream processes. To translate ASO-b...

Alternative Titles

Full title

Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7355792

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7355792

Other Identifiers

ISSN

2077-0383

E-ISSN

2077-0383

DOI

10.3390/jcm9062004

How to access this item